| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $1.6B | $1.0B | $1.4B | $1.1B | $1.5B |
| Cost of Revenue | — | — | — | — | $0.7B |
| Gross Profit | — | — | — | — | — |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| Operating Income | $0.5B | $-0.3B | $-0.1B | $0.2B | $0.4B |
| Net Income | $0.4B | $-0.3B | $-0.1B | $0.2B | $0.4B |
| EPS (Basic) | $1.95 | $-1.29 | $-0.48 | $0.92 | $1.70 |
| EPS (Diluted) | $1.85 | $-1.29 | $-0.48 | $0.89 | $1.63 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $6.1B | $5.2B | $5.4B | $5.3B | $5.2B |
| Current Assets | $1.3B | $1.0B | $1.2B | $1.4B | $1.6B |
| Cash & Equivalents | $0.5B | $0.4B | $0.5B | $0.7B | $1.0B |
| Total Liabilities | $1.8B | $1.2B | $1.1B | $1.1B | $1.2B |
| Current Liabilities | $0.6B | $0.2B | $0.2B | $0.3B | $0.3B |
| Stockholders' Equity | $3.5B | $3.1B | $3.4B | $3.6B | $3.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.0B | $0.4B | $0.2B | $0.6B |
| Investing Cash Flow | $-0.3B | $-0.1B | $-0.3B | $-0.2B | $-0.1B |
| Capital Expenditures | $0.2B | $0.1B | $0.2B | $0.1B | $0.2B |
| Financing Cash Flow | $0.0B | $0.0B | $-0.2B | $-0.3B | $-0.3B |